[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100616741":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":20,"locations":10,"responsibleParty":28,"collaborators":10,"id":30,"slug":31,"hasResults":32,"nctId":33,"briefTitle":34,"officialTitle":35,"acronym":36,"eligibilityCriteria":37,"healthyVolunteers":32,"sex":38,"minAge":39,"maxAge":10,"enrollmentInfo":40,"targetDuration":10,"studyType":43,"phases":10,"briefSummary":44,"conditions":45,"keywords":48,"overallStatus":55,"whyStopped":10,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":10},{"fullName":5,"class":6},"Universidad de la Sabana","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"All patients present on or admitted to a contributing ICU on the study day",null,"None interventions",[13,17],{"name":14,"affiliation":15,"role":16},"Ignacio-Martin Loeches, MD, PhD, FJFICMI","St James' Hospital. Dublin, Ireland","PRINCIPAL_INVESTIGATOR",{"name":18,"affiliation":19,"role":16},"Jean-Louis Vincent, MD, PhD","Erasme University Hospital. Brussels, Belgium",[21,26],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Luis Felipe Reyes, MD, MSc, PhD","CONTACT","+57 317 5130128","luis.reyes5@unisabana.edu.co",{"name":14,"role":23,"phone":10,"phoneExt":10,"email":27},"drmartinloeches@gmail.com",{"type":29,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100616741","the-extended-study-of-prevalence-of-infection-in-intensive-care-iv-100616741",false,"NCT07309549","The Extended Study of Prevalence of Infection in Intensive Care IV","The Extended Study of Prevalence of Infection in Intensive Care IV (EPIC IV)","EPIC IV","Inclusion Criteria:\n\n* All adult patients (\\>18 years) treated in the participating ICUs on the study day.\n\nExclusion Criteria:\n\n* Patients under 18 years","ALL","18 Years",{"count":41,"type":42},10000,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to learn how common infections are in intensive care units (ICUs) around the world and how they are treated. The study will look at all adults in the ICU during a single 24-hour period. The main questions it aims to answer are:\n\n* What types of infections and antibiotic-resistant bacteria are most common in ICUs worldwide?\n* How do resistance patterns affect how participants are treated and how they recover?\n\nHow are antibiotics used in ICUs, and how do hospitals practice antibiotic stewardship?\n\n* What organ support treatments do participants with infections receive?\n* What are the outcomes of participants with severe infections, including survival at hospital discharge (up to 60 days)?\n\nResearchers will compare ICUs across regions and income levels to see how infection patterns, treatments, and outcomes differ around the world.\n\nParticipants will:\n\n* Be counted if they are present in the ICU at any time during the study day.\n* Have information collected from their medical record about their health, the infection they may have, treatments they receive, and their outcome at ICU and hospital discharge (up to 60 days).\n\nBecause this is an observational study, participants will not receive any new treatments as part of the study.",[46,47],"Sepsis","Infection",[49,50,51,52,53,54],"Intensive Care Unit","Critical Illness","Severe Infection","Organ Dysfunction","ICU Outcomes","Global Prevalence","NOT_YET_RECRUITING","2026-06-24",{"date":58,"type":59},"2026-06-29","ACTUAL",{"date":61,"type":42},"2027-02-01",{"date":63,"type":42},"2027-06",{"name":5,"class":6}]